The Baker Ruskinn OxyGenie presents a compact and portable solution for researchers conducting short-term studies under controlled oxygen conditions. This innovative system allows for the creation of either hypoxic (low-oxygen) or physioxic (normal oxygen) environments, ideal for a variety of cell culture applications.

OxyGenie’s portability makes it highly versatile, enabling researchers to use it within a fume hood, incubator, or even transport samples for analysis. This flexibility streamlines workflows and facilitates the integration of hypoxia/physoxia studies into existing research protocols. The system’s ability to maintain consistent oxygen levels ensures reliable and reproducible results, making it a valuable tool for:

Investigating cellular responses to oxygen fluctuations: Researchers can study how cells adapt to changes in oxygen availability, providing insights into various physiological processes and disease pathologies.

Drug screening under controlled oxygen conditions: OxyGenie allows for testing the efficacy and safety of potential drugs under both hypoxic and normoxic conditions, mimicking the body’s natural environment for more accurate results.

Preserving samples for downstream analysis: Cells or tissues can be maintained in a defined oxygen environment prior to further analysis, ensuring the integrity of the samples and minimising the impact of oxygen changes on downstream experiments.

By offering a portable and user-friendly platform for short-term hypoxia and physoxia studies, the OxyGenie empowers researchers to explore the complex interplay between oxygen levels and cellular function.

All life science related research can now utilise technology delivering controlled, physiologically relevant conditions at an economical price! Get results equivalent to research carried out within an InvivO2 workstation with OxyGenie (cell morphology and cell health).

Based on the technology developed by BioMediTech – Institute of Biosciences and Medical Technology, Tampere, Finland.